153 related articles for article (PubMed ID: 32413418)
1. Unique aspects of Graft-versus-host-disease management in the Eastern Mediterranean region: Report from the Eastern Mediterranean blood and marrow transplantation group: Special report.
Hashmi S; Shaheen M; Adil S; Ahmed P; Ahmed S; Ben Abdeljelil N; Alabdulwahab A; Albeihany A; Aldaama S; Al-Khabori M; Alkindi S; Almohareb F; Alsaeed A; Alseraihy A; Alshemari S; Ayas M; Chaudhri N; Da'na W; Dennison D; ElQuessar A; Elhaddad A; Ibrahim A; Hashem H; Jastaniah W; Mawardi H; Nassar A; Satti T; Torjemane L; Tabbara K; El Solh H; Albeirouti B; Aljurf M
Hematol Oncol Stem Cell Ther; 2023 May; 16(4):303-306. PubMed ID: 32413418
[No Abstract] [Full Text] [Related]
2. Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2011-2012: A comprehensive report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation group (EMBMT).
Aljurf M; Nassar A; Hamidieh AA; Elhaddad A; Hamladji RM; Bazarbachi A; Ibrahim A; Ben Othman T; Abdel-Rahman F; Alseraihy A; Fahmy O; Hussein AA; Alabdulaaly A; Adil S; Alkindi SS; Bayoumy M; Dennison D; Bekadja MA; Redhouane AN; Rasheed W; AlSagheir A; Alsudairy R; Ladeb S; Benchekroun S; Ramzi M; Ahmed P; ElSolh H; Ahmed SO; Hussain F; Ghavamzadeh A
Hematol Oncol Stem Cell Ther; 2015 Dec; 8(4):167-75. PubMed ID: 26452331
[TBL] [Abstract][Full Text] [Related]
3. Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults.
Mehta RS; Peffault de Latour R; DeFor TE; Robin M; Lazaryan A; Xhaard A; Bejanyan N; de Fontbrune FS; Arora M; Brunstein CG; Blazar BR; Weisdorf DJ; MacMillan ML; Socie G; Holtan SG
Haematologica; 2016 Jun; 101(6):764-72. PubMed ID: 27036159
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and management of acute graft-versus-host disease.
Dignan FL; Clark A; Amrolia P; Cornish J; Jackson G; Mahendra P; Scarisbrick JJ; Taylor PC; Hadzic N; Shaw BE; Potter MN; ;
Br J Haematol; 2012 Jul; 158(1):30-45. PubMed ID: 22533831
[TBL] [Abstract][Full Text] [Related]
5. Impact of graft composition on outcomes of haploidentical bone marrow stem cell transplantation.
Saliba RM; Veltri L; Rondon G; Chen J; Al-Atrash G; Alousi A; Martinez C; Augustine L; Hosing CM; Oran B; Rezvani K; Shpall EJ; Kebriaei P; Khouri IF; Popat U; Champlin RE; Ciurea SO
Haematologica; 2021 Jan; 106(1):269-274. PubMed ID: 32107328
[No Abstract] [Full Text] [Related]
6. Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2008-2009: report on behalf of the Eastern Mediterranean Bone Marrow Transplantation (EMBMT) Group.
Mohamed SY; Fadhil I; Hamladji RM; Hamidieh AA; Fahmy O; Ladeb S; Alimoghaddam K; Elhaddad A; Nacer RA; Alsharif F; Rasheed W; Jahani M; Mousavi SA; Alseraihy A; Abdel-Rahman F; Al Jefri A; Hussein AA; Alabdulaaly A; Ibrahim A; Bekadja MA; Abboud M; Ahmed P; Dennison D; Bakr M; Benchekroun S; Hussain F; Othman TB; Aljurf M; Ghavamzadeh A
Hematol Oncol Stem Cell Ther; 2011; 4(2):81-93. PubMed ID: 21727769
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic stem cell transplantation practice variation among centers in the Eastern Mediterranean Region (EMRO): Eastern Mediterranean Bone Marrow Transplantation (EMBMT) group survey.
Rasheed W; Ghavamzadeh A; Hamladji R; Ben Othman T; Alseraihy A; Abdel-Rahman F; Elhaddad A; Alabdulaaly A; Dennison D; Ibrahim A; Bazarbachi A; Bekadja MA; Mohamed SY; Adil SN; Ahmed P; Benchekroun S; Ramzi M; Jarrar M; Alimoghaddam K; Hussain F; Hamidieh A; Aljurf M
Hematol Oncol Stem Cell Ther; 2013 Mar; 6(1):14-9. PubMed ID: 23664600
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and management of chronic graft-versus-host disease.
Dignan FL; Amrolia P; Clark A; Cornish J; Jackson G; Mahendra P; Scarisbrick JJ; Taylor PC; Shaw BE; Potter MN; ;
Br J Haematol; 2012 Jul; 158(1):46-61. PubMed ID: 22533811
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups.
Bacigalupo A; Socié G; Schrezenmeier H; Tichelli A; Locasciulli A; Fuehrer M; Risitano AM; Dufour C; Passweg JR; Oneto R; Aljurf M; Flynn C; Mialou V; Hamladji RM; Marsh JC;
Haematologica; 2012 Aug; 97(8):1142-8. PubMed ID: 22315497
[TBL] [Abstract][Full Text] [Related]
10. The Pathophysiology and Treatment of Graft-
Teshima T; Hill GR
Front Immunol; 2021; 12():715424. PubMed ID: 34489966
[TBL] [Abstract][Full Text] [Related]
11. Acute graft-versus-host disease following hematopoietic stem-cell transplantation.
Hu SW; Cotliar J
Dermatol Ther; 2011; 24(4):411-23. PubMed ID: 21910799
[TBL] [Abstract][Full Text] [Related]
12. Haploidentical bone marrow transplantation in a child with fatal hepatic failure due to graft-versus-host disease after cord blood transplantation.
Ito M; Yagasaki H; Nakahara E; Okuma H; Hirai M; Chin M; Morioka I
Leuk Lymphoma; 2020 May; 61(5):1263-1264. PubMed ID: 31876210
[No Abstract] [Full Text] [Related]
13. Rehabilitation in Chronic Graft-Versus-Host Disease.
Smith SR; Asher A
Phys Med Rehabil Clin N Am; 2017 Feb; 28(1):143-151. PubMed ID: 27912993
[TBL] [Abstract][Full Text] [Related]
14. Occult alloimmunization to the D antigen (RhD) related to graft versus host disease and its treatment.
Badami KG; O'Brien J; Prestidge T
Transfus Clin Biol; 2022 May; 29(2):175-176. PubMed ID: 34923150
[TBL] [Abstract][Full Text] [Related]
15. [Complications of hematopoietic stem cell transplantation: physiopathology and management. 2. Graft-versus-host disease (GVHD)].
Morishita Y
Nihon Naika Gakkai Zasshi; 1998 Aug; 87(8):1502-9. PubMed ID: 9780678
[No Abstract] [Full Text] [Related]
16. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.
Rocha V; Wagner JE; Sobocinski KA; Klein JP; Zhang MJ; Horowitz MM; Gluckman E
N Engl J Med; 2000 Jun; 342(25):1846-54. PubMed ID: 10861319
[TBL] [Abstract][Full Text] [Related]
17. Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups.
Inamoto Y; Kimura F; Kanda J; Sugita J; Ikegame K; Nakasone H; Nannya Y; Uchida N; Fukuda T; Yoshioka K; Ozawa Y; Kawano I; Atsuta Y; Kato K; Ichinohe T; Inoue M; Teshima T;
Haematologica; 2016 Dec; 101(12):1592-1602. PubMed ID: 27662017
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.
Holtick U; Albrecht M; Chemnitz JM; Theurich S; Skoetz N; Scheid C; von Bergwelt-Baildon M
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD010189. PubMed ID: 24748537
[TBL] [Abstract][Full Text] [Related]
19. Rescue from canine graft-versus-host reaction by autologous or DL-A-compatible marrow.
Storb R; Epstein RB; Graham TC; Kolb HJ; Kolb H; Thomas ED
Transplantation; 1974 Oct; 18(4):357-67. PubMed ID: 4154059
[No Abstract] [Full Text] [Related]
20. [Allogeneic peripheral blood stem cell transplantation (allo PBSCT) compared with allogeneic bone marrow transplantation (allo BMT)].
Tanaka J
Rinsho Ketsueki; 2002 Jun; 43(6):442-6. PubMed ID: 12134697
[No Abstract] [Full Text] [Related]
[Next] [New Search]
